Kodiak Sciences Inc

KOD’s Stage 2 advancing environment, with a clear HH/HL sequence above rising EMAs and the 50 DMA, supported by an active Lockout Rally, favors continuation participation. Despite extreme overbought readings, the Lockout Rally override and tight EMA tracking justify Buy Now. Key risks include failure of rising EMAs or resistance at recent highs triggering sharper pullbacks.

• ↑Call options volume jumped 572%, indicating strong bullish trader activity.
• ↑Consensus Moderate Buy rating with average $42.14 target supports upside.
• ↓Last quarter net loss $58.2M highlights cash flow challenges.